clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Coronavirus
Mini Lungs Reveal More Cells Susceptible to COVID-19
News & Features
Antimicrobial Susceptibility Test Turnaround Time Slashed by Novel Method
News & Features
New Therapeutic Target Found for Acute Myeloid Leukemia
News & Features
Fecal Microbiota Transplants Could Boost Cancer Immunotherapy Efficacy
News & Features
New Research Shows Potential for Ketone Therapy in Heart Failure
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
LLS Doubles Pediatric Cancer Research Funding Through $50M Children’s Initiative
Chemotherapy
News & Features
LLS Doubles Pediatric Cancer Research Funding Through $50M Children’s Initiative
Alex Philippidis
-
August 29, 2019
0
News & Features
New Diagnostic Approach Predicts Treatment Response for NSCLC Patients
Chris Anderson
-
August 27, 2019
0
Molecular Dx
Urine Better than Blood for Determining Bladder Cancer Genomic Profile
Camille Mojica Rey, PhD
-
August 8, 2019
0
Molecular Dx
Portable Device Measures Efficacy of Targeted Cancer Drugs
Camille Mojica Rey, PhD
-
July 17, 2019
0
Molecular Dx
Response to Targeted Therapies Depends on Cancer Type
Camille Mojica Rey, PhD
-
July 2, 2019
0
News & Features
Risk Score May Point to Which Breast Cancer Patients Can Avoid Chemo
Camille Mojica Rey, PhD
-
July 1, 2019
0
Molecular Dx
Multi-Gene Testing More Cost-Effective if Patients Receive Indicated Therapy
Camille Mojica Rey, PhD
-
June 27, 2019
0
News & Features
New Drug Could Improve Response to Chemotherapy
Malorye Branca
-
June 6, 2019
0
News & Features
Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor
Malorye Branca
-
June 3, 2019
0
News & Features
Triple Negative Breast Cancers Activate Resistance Pathway to Evade Chemotherapy
Chris Anderson
-
April 18, 2019
0
1
...
23
24
25
26
Page 24 of 26
Related Content
New Therapeutic Target Found for Acute Myeloid Leukemia
Novel Technique Reprograms B cells, Boosting Them to Fight Cancer
Sequencing Rates Unacceptably Low in Metastatic Prostate and Urothelial Cancers
Second HIV Patient “Cured” with Stem Cell Transplant at Charité, Using Slightly Different Genetic Recipe
Inside Precision Medicine
![A three-protein biomarker panel has been established that is able to screen urine samples for signs of early-stage pancreatic cancer. [iStock/© David Marchal]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/289.jpeg "Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor")
